Skip to main content
. 2023 Jun 2;396(12):3595–3603. doi: 10.1007/s00210-023-02553-y

Fig. 3.

Fig. 3

Predicted molecular mechanism of action of BBR LCNP treatment on A549 cells. A The normal state of WNT/β-catenin pathway is shown, where binding of WNT molecules leads to the activation of β-catenin resulting in tumorigenesis. B Inhibition of AXIN1 and β-catenin by BBR LCNPs is shown